Neurotransmitters are chemical messengers that allow neurons in the brain to communicate with one another. They have widespread effects in the body, from influencing cognitive processes like memory and concentration, to contributing to the regulation of hormones, body temperature, appetite, and more. Neurotransmitters act as a bridge between neurons, carrying a message from one neuron to another, or even to multiple neurons. They can be either excitatory — when they cause increased activity or responses in the neurons — or inhibitory — when they decrease activity or responses in the neurons. The most well-known neurotransmitters are the small molecules acetylcholine, glutamate, and dopamine. Acetylcholine plays a role in learning, memory and muscle control, and is responsible for many of the processes associated with attention. Glutamate is responsible for the excitatory signals between neurons, and is involved in muscle control and determining how we respond to sensory stimuli. Dopamine is a catecholamine neurotransmitter and is associated with learning, reward, and motivation. The function of neurotransmitters depends on the type and amount released by the pre-synaptic neuron. If too much or too little is released, the message transmitted from the neuron to the target neuron may become distorted or interrupted. There are several factors that contribute to neurotransmitter release, such as environmental stimuli, genes, and hormones. Neurotransmitters play an essential role in normal brain function. Imbalances in neurotransmitter levels can lead to neurological disorders such as depression, anxiety, and addiction. To address these issues, medications are often used to regulate levels of the chemicals. In some cases, lifestyle changes such as reducing stress or improving nutrition can also help to improve the functioning of neurotransmitters.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States